Extending political will into action in African LMICs: abating global antimicrobial resistance.
作者信息
Aruhomukama Dickson
机构信息
Department of Immunology and Molecular Biology and Department of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala 7062, Uganda.
出版信息
Lancet Microbe. 2022 May;3(5):e327-e328. doi: 10.1016/S2666-5247(22)00063-5. Epub 2022 Mar 22.
Abstract
摘要
相似文献
1
Extending political will into action in African LMICs: abating global antimicrobial resistance.
Lancet Microbe. 2022 May;3(5):e327-e328. doi: 10.1016/S2666-5247(22)00063-5. Epub 2022 Mar 22.
2
Antimicrobial resistance in low- and middle-income countries: current status and future directions.
Expert Rev Anti Infect Ther. 2022 Feb;20(2):147-160. doi: 10.1080/14787210.2021.1951705. Epub 2021 Jul 19.
3
Post COVID Antimicrobial Resistance Threat in Lower- and Middle-Income Countries: Bangladesh.
Front Public Health. 2021 Dec 17;9:770593. doi: 10.3389/fpubh.2021.770593. eCollection 2021.
4
Global surveillance of antimicrobial resistance and hypervirulence in Klebsiella pneumoniae from LMICs: An in-silico approach.
Sci Total Environ. 2022 Jan 1;802:149859. doi: 10.1016/j.scitotenv.2021.149859. Epub 2021 Aug 25.
5
Creating political commitment for antimicrobial resistance in developing countries.
Indian J Med Res. 2019 Feb;149(2):83-86. doi: 10.4103/ijmr.IJMR_1980_17.
6
Policy entrepreneurs are integral in efforts to curb antimicrobial resistance in low and middle income countries.
Front Public Health. 2024 Mar 12;12:1292660. doi: 10.3389/fpubh.2024.1292660. eCollection 2024.
7
Benchmarking national action plans on antimicrobial resistance in eight selected LMICs: Focus on the veterinary sector strategies.
J Glob Health. 2020 Dec;10(2):020414. doi: 10.7189/jogh.10.020414.
8
Differential Drivers of Antimicrobial Resistance across the World.
Acc Chem Res. 2019 Apr 16;52(4):916-924. doi: 10.1021/acs.accounts.8b00643. Epub 2019 Mar 8.
9
Antimicrobial resistance: translating political commitment into national action.
Bull World Health Organ. 2017 Apr 1;95(4):242. doi: 10.2471/BLT.17.191890.
10
Developing bespoke antimicrobials to combat antimicrobial resistance in low- and middle-income countries: A critical appraisal of clinical utility in the elderly.
Maturitas. 2023 Apr;170:74-75. doi: 10.1016/j.maturitas.2022.11.007. Epub 2022 Dec 2.
引用本文的文献
1
Policy entrepreneurs are integral in efforts to curb antimicrobial resistance in low and middle income countries.
Front Public Health. 2024 Mar 12;12:1292660. doi: 10.3389/fpubh.2024.1292660. eCollection 2024.
2
Health systems appraisal of the response to antimicrobial resistance in low- and middle-income countries in relation to COVID-19: Application of the WHO building blocks.
Glob Policy. 2023 Nov;14(5):790-796. doi: 10.1111/1758-5899.13262. Epub 2023 Aug 22.
3
Investigating the evolution and predicting the future outlook of antimicrobial resistance in sub-saharan Africa using phenotypic data for Klebsiella pneumoniae: a 12-year analysis.
BMC Microbiol. 2023 Aug 8;23(1):214. doi: 10.1186/s12866-023-02966-y.
Zotero 插件